acquired immunodeficiency syndrome
Information
- Disease name
- acquired immunodeficiency syndrome
- Disease ID
- DOID:635
- Description
- "A Human immunodeficiency virus infectious disease that results_in reduction in the numbers of CD4-bearing helper T cells below 200 per microliter of blood or 14% of all lymphocytes thereby rendering the subject highly vulnerable to life-threatening infections and cancers, has_material_basis_in Human immunodeficiency virus 1 or has_material_basis_in Human immunodeficiency virus 2, which are transmitted_by sexual contact, transmitted_by transfer of blood, semen, vaginal fluid, pre-ejaculate, or breast milk, transmitted_by congenital method, and transmitted_by contaminated needles. Opportunistic infections are common in people with AIDS." [url:http\://en.wikipedia.org/wiki/AIDS, url:http\://www2.merriam-webster.com/cgi-bin/mwmednlm?book=Medical&va=aids]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02639754 | Active, not recruiting | N/A | Community Intervention for HIV Testing & Care Linkage Among Young MSM in Bulgaria | December 2015 | July 2024 |
| NCT00000134 | Completed | Phase 3 | Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT) | December 1992 | March 1995 |
| NCT00000168 | Completed | Longitudinal Study of Ocular Complications of AIDS (LSOCA) | August 1998 | August 2013 | |
| NCT00000587 | Completed | Phase 2 | Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection | September 1988 | January 2005 |
| NCT00000590 | Completed | Phase 3 | Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185) | September 1991 | December 1996 |
| NCT00000593 | Completed | N/A | Viral Activation Transfusion Study (VATS) | November 1994 | March 2001 |
| NCT00001267 | Completed | Phase 3 | A Randomized Pilot Study for the Treatment of AIDS or AIDS Related Complex With an Alternating or Simultaneous Combination Regimen of AZT and 2',3'-Dideoxyinosine | October 1990 | April 2000 |
| NCT00001353 | Completed | Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs | March 1993 | March 2002 | |
| NCT00001354 | Completed | Phase 2 | Interleukin-2 Therapy for HIV Infection - Supplemental Procedures | March 1993 | March 2002 |
| NCT00001386 | Completed | Phase 1 | Phase I Protocol for the Evaluation of the Safety and Immunogenicity of Vaccination With Synthetic HIV Envelope Peptides in Patients With Early Human Immunodeficiency Virus Infection | June 1994 | January 2002 |
| NCT00001409 | Completed | Phase 1 | Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications | September 1994 | June 2002 |
| NCT00001424 | Completed | Evaluation and Natural History of Children With Cancer and AIDS | November 1994 | August 2000 | |
| NCT00001435 | Completed | Psychosocial Correlates and Coping Strategies Associated With Long-Term Survival of HIV-Infected Children | April 1995 | December 2000 | |
| NCT00001443 | Completed | Phase 1 | A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection | July 1995 | October 2000 |
| NCT00001475 | Completed | Phase 2 | Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist | June 1995 | June 2002 |
| NCT00001500 | Completed | Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits | April 1996 | July 2004 | |
| NCT00001524 | Completed | Phase 2 | Thalidomide to Treat Oral Lesions in HIV-Infected Patients | June 1996 | December 2004 |
| NCT00001535 | Completed | Phase 1 | Twins Study of Gene Therapy for HIV Infection | March 1996 | March 2002 |
| NCT00001538 | Completed | Phase 1 | Phase I Study of APL 400-003, a Candidate HIV Vaccine, in HIV-Negative Volunteers | March 1996 | April 2001 |
| NCT00001542 | Completed | Phase 4 | Fluconazole Prophylaxis of Thrush in AIDS | July 1996 | November 2001 |
| NCT00001560 | Completed | Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers | December 24, 1996 | October 31, 2011 | |
| NCT00001611 | Completed | Immune Activity Against CVM Retinitis | February 1997 | April 2004 | |
| NCT00001646 | Completed | Phase 3 | Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis | August 1997 | August 2000 |
| NCT00001647 | Completed | Phase 1 | White Blood Cell Infusions to Treat HIV Infection | August 1997 | August 2002 |
| NCT00001650 | Completed | Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients | September 19, 1997 | May 13, 2011 | |
| NCT00001699 | Completed | A Pilot Study of Adherence to Oral Medication and Health Beliefs of Adolescents With HIV and Their Mothers | June 1998 | March 2000 | |
| NCT00001763 | Completed | Phase 1 | Subcutaneously Administered Interleukin-12 Therapy in HIV-Infected Patients With Disseminated Mycobacterium Avium Complex Infection | April 1998 | March 2000 |
| NCT00001968 | Completed | Phase 1 | Once-Daily Drug Regimen for HIV-Infected Patients | January 2000 | November 2000 |
| NCT00004664 | Completed | N/A | Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-Wasting | June 1995 | |
| NCT00004794 | Completed | Phase 2 | Phase II Randomized Study of Cidofovir for Peripheral Cytomegalovirus Retinitis | March 1995 | |
| NCT00005227 | Completed | AIDS-Associated Cardiomyopathy | July 1988 | June 1993 | |
| NCT00005228 | Completed | AIDS-Associated Heart Disease -- Incidence and Etiology | July 1988 | June 1993 | |
| NCT00005229 | Completed | HIV-Associated Heart Disease | July 1988 | June 1993 | |
| NCT00005273 | Completed | Pulmonary Complications of HIV Infection Study (PACS) | September 1987 | May 1997 | |
| NCT00005274 | Completed | Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) | May 1989 | March 2003 | |
| NCT00005278 | Completed | Retrovirus Epidemiology Donor Study I (REDS I) | July 1989 | October 2007 | |
| NCT00000118 | Completed | Phase 3 | Ganciclovir Implant Study for Cytomegalovirus Retinitis | October 1992 | December 1993 |
| NCT00005303 | Completed | Effectiveness of AIDS Antibody Screening | September 1986 | September 1995 | |
| NCT00005309 | Completed | Prospective Study of HIV Infection in Hemophiliacs | July 1990 | March 1995 | |
| NCT00005353 | Completed | Cardiac Autonomic Control in Children of HIV Positive Mothers | June 1992 | May 1995 | |
| NCT00005360 | Completed | HIV Diversity and Pathogenesis in Donor-Recipient Clusters | August 1992 | July 1997 | |
| NCT00005379 | Completed | Tuberculosis in a Multiethnic Inner City Population | August 1994 | July 1999 | |
| NCT00006310 | Completed | KSHV Infection in Blood Donors From Texas | April 1999 | March 2004 | |
| NCT00032721 | Completed | Phase 2 | The Use of Reiki for Patients With Advanced AIDS | March 2002 | September 2003 |
| NCT00033176 | Completed | Phase 2 | Immune Restoration by Lipoic Acid in AIDS | February 2002 | August 2004 |
| NCT00033852 | Completed | Phase 2 | Treatment of Depression With Massage in HIV | April 2002 | May 2004 |
| NCT00068978 | Completed | Analysis of Immune Responses to HIV Vaccines | April 2003 | ||
| NCT00091884 | Completed | Efficacy of Elevated CD4 Counts on CMV Retinitis | July 2004 | April 2005 | |
| NCT00097006 | Completed | Retrovirus Epidemiology Donor Study-II (REDS-II) | September 2004 | September 2009 | |
| NCT00100048 | Completed | Phase 2 | A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED) | January 2005 | July 2010 |
| NCT00105157 | Completed | Phase 2 | Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED) | March 2005 | July 2009 |
| NCT00144157 | Completed | Phase 4 | Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV | June 2003 | July 2006 |
| NCT00144183 | Completed | Phase 3 | A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS) | January 2003 | January 2007 |
| NCT00005301 | Completed | Transfusion Safety Study (TSS) | September 1984 | February 1998 | |
| NCT01916759 | Completed | N/A | Differences in Response to the Flu Vaccine Among Adults With HIV and Without HIV in Uganda | June 2013 | March 2014 |
| NCT01967940 | Completed | Phase 3 | Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults | October 25, 2013 | July 31, 2017 |
| NCT01968551 | Completed | Phase 3 | Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults | September 3, 2013 | July 9, 2016 |
| NCT02116179 | Completed | N/A | DVD-based HIV/HCV Prevention Intervention for Drug-Involved Latino Criminal Justice Clients | July 2014 | May 2016 |
| NCT02191215 | Completed | Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS | June 2003 | ||
| NCT02264509 | Completed | Peripheral Arterial Insufficiency Associated With HIV/AIDS | September 2014 | December 2014 | |
| NCT02322827 | Completed | Adherence & Health Outcome Differences Amongst HIV Infected Patients Prescribed HAART | November 2014 | October 2016 | |
| NCT02348177 | Completed | Phase 4 | Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB | January 2013 | December 2016 |
| NCT02396355 | Completed | Accuracy Evaluation of the BD FACS Presto System | February 2015 | May 2015 | |
| NCT02396979 | Completed | Phase 4 | Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia | January 2010 | December 2014 |
| NCT02583464 | Completed | Phase 1 | Bioequivalence Study of Two Formulations With the Association of Tenofovir 300 mg and Emtricitabine 200 mg. | September 2014 | December 2014 |
| NCT02630082 | Completed | N/A | Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru | April 2011 | March 2013 |
| NCT02929069 | Completed | N/A | A Unified Intervention for Young Gay and Bisexual Men's Minority Stress, Mental Health, and HIV Risk | September 2016 | June 16, 2020 |
| NCT03583138 | Completed | HIV, Buprenorphine, and the Criminal Justice System (STRIDE2) | June 23, 2014 | June 30, 2017 | |
| NCT03746600 | Completed | N/A | Technological Intervention for Reducing Alcohol Use Among People Living With HIV/AIDS | June 5, 2019 | June 7, 2023 |
| NCT03777371 | Completed | Anti-HIV False Positivity Rate in Pregnant Women; and Investigating the Factors Affecting This Situation | January 1, 2014 | December 1, 2018 | |
| NCT04122404 | Completed | N/A | POC Strategies to Improve TB Care in Advanced HIV Disease | October 14, 2019 | January 30, 2022 |
| NCT04192487 | Completed | Phase 4 | Effects of Crofelemer on the Gut Microbiome in Healthy Volunteers and in HIV+ Patients With Non-Infectious Diarrhea | October 22, 2019 | August 31, 2021 |
| NCT04772469 | Completed | N/A | Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men | March 22, 2021 | April 26, 2023 |
| NCT00241202 | Completed | N/A | The Efficacy of the HIV/AIDS Symptom Management Manual | October 2005 | December 2006 |
| NCT00269945 | Completed | Phase 2 | A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease | January 1989 | |
| NCT00270010 | Completed | Phase 2 | A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease | August 1989 | |
| NCT00270270 | Completed | Phase 2 | A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy | July 1989 | |
| NCT00270283 | Completed | Phase 2 | A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy | July 1988 | April 1990 |
| NCT00272220 | Completed | N/A | Longitudinal Study of HAART, Social Networks, & Adherence | October 2004 | June 2006 |
| NCT00273988 | Completed | Phase 4 | Pharmacokinetic Study of Interaction Between Nevirapine and Methadone in HIV-1 Infected, Opioid-dependent Adults | April 2002 | October 2003 |
| NCT00312468 | Completed | Examining the Link Between Heart Disease and HIV Infection in Women | October 2006 | December 31, 2012 | |
| NCT00325585 | Completed | Phase 2 | HIV Prevention Intervention for Couples | April 2005 | June 2008 |
| NCT00325611 | Completed | N/A | Multidisciplinary Inpatient Palliative Care Intervention | April 2002 | July 2004 |
| NCT00344591 | Completed | Phase 2 | Effectiveness of Structured Ecosystems Therapy for Reducing HIV Risk Behaviors and Improving Treatment Adherence in HIV Infected Men Released From Prison | January 2005 | |
| NCT00381212 | Completed | Phase 1/Phase 2 | A Pilot Study to Investigate the Safety and Immunologic Activity AGS-004 an Autologous HIV Immunotherapeutic Agent. | September 2006 | November 2008 |
| NCT00394004 | Completed | Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical Trials | October 26, 2006 | April 26, 2011 | |
| NCT00434070 | Completed | Relationship of Viral Resistance Development to CD4 Monitoring Alone or With Viral Load Monitoring | February 7, 2007 | February 7, 2013 | |
| NCT00443378 | Completed | N/A | Computer Assisted Rx Education for HIV-Positives: CARE+ | March 2006 | July 2007 |
| NCT00474370 | Completed | Phase 3 | Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED) | May 15, 2007 | October 26, 2010 |
| NCT00478231 | Completed | Phase 3 | Multicenter, Safety Study Of Maraviroc | July 2007 | September 2010 |
| NCT00523211 | Completed | Phase 3 | Vicriviroc in HIV-Treatment Experienced Subjects (Study P04405AM5) | July 2007 | March 2011 |
| NCT00551330 | Completed | Phase 2 | Vicriviroc in HIV(R5/X4)-Treatment Experienced Subjects (Study P05057AM5)(COMPLETED) | September 2007 | May 2010 |
| NCT00602758 | Completed | N/A | Effectiveness of Enhanced Counseling and Observed Therapy on Antiretroviral Adherence in People With HIV | December 2004 | August 2009 |
| NCT00698334 | Completed | Phase 3 | Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis | April 2006 | April 2011 |
| NCT00871078 | Completed | Anatomic and Visual Function Assessments on Asymptomatic HIV-positive Patients | June 2008 | September 2009 | |
| NCT00896051 | Completed | Phase 2 | TMC125-TiDP2-C238: An Exploratory Pharmacokinetics, Safety and Anti-HIV Activity Study of Etravirine (ETR) When Given With Boosted Atazanavir (ATV/Rtv) at Two Different Doses and 1 Nucleoside Reverse Transcriptase Inhibitor (NRTI) in Treatment Experienced HIV Patients | August 2009 | April 2012 |
| NCT00903682 | Completed | Phase 2 | A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients | June 2009 | January 2011 |
| NCT00908284 | Completed | N/A | Evaluating an Exercise Program to Reduce Cardiovascular Risk Factors in Children Infected With HIV | December 2008 | November 2015 |
| NCT00917891 | Completed | Phase 1/Phase 2 | An Expanded Safety Study of Dapivirine Gel 4759 in Africa | November 2009 | September 2011 |
| NCT00917904 | Completed | Phase 1/Phase 2 | An Expanded Safety Study of Dapivirine Gel 4789 in Africa | July 2009 | September 2010 |
| NCT00947947 | Completed | Phase 2 | Computerized HIV/Sexually Transmitted Disease (STD) Prevention Program | February 2010 | May 2012 |
| NCT00966160 | Completed | Phase 3 | CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes | January 1999 | December 2008 |
| NCT00985543 | Completed | Phase 1 | Pharmacokinetics of Lopinavir/Ritonavir at Three Different Doses. | October 2009 | January 2010 |
| NCT01038076 | Completed | N/A | Medications for Chronic HIV: Education and Collaboration | December 2009 | December 2017 |
| NCT01086878 | Completed | Phase 4 | Safety of Cotrimoxazole in HIV- and HAART-exposed Infants | February 2009 | October 2010 |
| NCT01090102 | Completed | Phase 4 | Mesalamine to Reduce T Cell Activation in HIV Infection | June 2010 | December 2012 |
| NCT01186575 | Completed | N/A | Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male Circumcision | August 2010 | June 2011 |
| NCT01210924 | Completed | Chinese Network of Pediatric Antiretroviral Therapy | April 2010 | December 2015 | |
| NCT01322217 | Completed | Managerial Database II | April 2011 | June 2012 | |
| NCT01363011 | Completed | Phase 3 | Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment | May 2011 | February 2015 |
| NCT01369056 | Completed | N/A | HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence | July 2010 | December 2011 |
| NCT01377272 | Completed | Spatial Epidemiology of HIV Infection | October 2008 | August 2009 | |
| NCT01401335 | Completed | N/A | HIV Prevention and Care of Psychological Trauma in Vulnerable Rwandan Youth | October 2009 | June 2011 |
| NCT01401348 | Completed | Stanford Universities: The Stanford HIV Aging Cohort | December 2010 | December 2015 | |
| NCT01425073 | Completed | N/A | Discontinuation of Trimethoprim-sulfamethoxazole Prophylaxis in Adults on Antiretroviral Therapy in Kenya | February 2012 | October 2013 |
| NCT01433185 | Completed | N/A | Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV | April 2012 | July 2013 |
| NCT01440569 | Completed | Phase 3 | Safety and Efficacy of Cobicistat-boosted Darunavir in HIV Infected Adults | September 2011 | October 2015 |
| NCT01455740 | Completed | N/A | A Commitment Device for Medication Adherence Among HIV Patients | October 2011 | October 2014 |
| NCT01475838 | Completed | Phase 3 | Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients | November 2011 | December 2014 |
| NCT01495702 | Completed | Phase 3 | Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients | December 2011 | December 2014 |
| NCT01497899 | Completed | Phase 2 | Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults | December 28, 2011 | August 22, 2016 |
| NCT01502618 | Completed | N/A | Intervention for HIV-Positive Black Young Men Who Have Sex With Men (YMSM) | August 2010 | January 2011 |
| NCT01533259 | Completed | Phase 3 | Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients | January 2012 | July 2013 |
| NCT01550341 | Completed | N/A | HIV, Buprenorphine, and the Criminal Justice System | February 23, 2012 | November 30, 2016 |
| NCT01565850 | Completed | Phase 2 | D/C/F/TAF Versus COBI-boosted DRV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment Naive Adults | April 2012 | February 2014 |
| NCT01590017 | Completed | Phase 2 | Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer | April 1, 2014 | April 20, 2017 |
| NCT01671501 | Completed | N/A | Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients | March 2013 | August 2017 |
| NCT01683461 | Completed | N/A | Efficacy of HIV Post-Test Support for ANC in South Africa | May 2008 | December 2011 |
| NCT01705574 | Completed | Phase 3 | Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women | October 24, 2012 | September 6, 2018 |
| NCT01721109 | Completed | Phase 2/Phase 3 | Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents | December 6, 2012 | January 29, 2018 |
| NCT01791556 | Completed | N/A | Clinic-based ART Diagnostic Evaluation | January 26, 2010 | August 2012 |
| NCT05685641 | Not yet recruiting | N/A | Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City | April 1, 2023 | September 30, 2024 |
| NCT06280001 | Not yet recruiting | A Multicenter Prospective Clinical Cohort Study on the Pathogen Spectrum of HIV/AIDS Complicated With Infection | March 2024 | November 2026 | |
| NCT05493969 | Not yet recruiting | Phase 4 | Efficacy and Tolerability of DTG Plus 3TC in HIV Infected Adults With Virologically Suppression and TDF Toxicity | August 2022 | June 2026 |
| NCT04983030 | Recruiting | Phase 1/Phase 2 | Safety, Immunogenicity, Efficacy of Ad26.Mos4.HIV, MVA-BN-HIV and PGT121, PGDM1400, and VRC07-523LS in HIV-1-Infected Adults | April 1, 2022 | April 30, 2026 |
| NCT02479698 | Recruiting | Phase 2 | Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus | July 23, 2015 | July 31, 2024 |
| NCT05031819 | Recruiting | N/A | Managing Hypertension Among People Living With HIV | October 26, 2022 | October 2025 |
| NCT00981318 | Terminated | Phase 4 | Pilot Assessment of Lopinavir/Ritonavir and Maraviroc | December 2009 | May 2015 |
| NCT00051766 | Terminated | N/A | Computer-Assisted Adherence Program for Patients Taking Anti-HIV Drugs | ||
| NCT05225493 | Unknown status | HIV Indicator Diseases in Hospital and Primary Care | January 1, 2020 | May 2024 | |
| NCT02762045 | Unknown status | Phase 1 | Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine | April 2016 | December 2017 |
| NCT01892228 | Unknown status | N/A | Pilot Study of Immediate HIV Treatment in Guangxi, China | July 2012 | July 2015 |
| NCT00172315 | Unknown status | Proton Magnetic Resonance Spectroscopy (1H MRS) in Evaluating the Bone Marrow, Muscle and Adipose Tissue on Normal and Human Immunodeficiency Virus Infected Subjects | December 2003 | ||
| NCT01444690 | Unknown status | Phase 2 | Dimiracetam in Painful Neuropathies Affecting AIDS Patients | January 2012 | January 2013 |
| NCT02392884 | Unknown status | N/A | HIV Medication Adherence in Underserved Populations | September 2014 | December 2015 |
| NCT01881581 | Unknown status | Phase 1 | Safety and Immunogenicity of Recombinant HIV Vaccines for HIV/AIDS | June 2013 | August 2014 |
| NCT01230580 | Unknown status | Phase 4 | Protease Inhibitor Monotherapy Versus Ongoing Triple-therapy in the Long Term Management of HIV Infection (PIVOT) | November 2008 | November 2013 |
| NCT01315301 | Unknown status | N/A | Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis | August 2008 | March 2012 |
| NCT00162643 | Unknown status | Phase 4 | PI Vs. NNRTI Based Therapy for HIV Advanced Disease | December 2004 | December 2007 |
| NCT00243568 | Withdrawn | Phase 3 | Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285 | September 1, 2005 |
- Disase is a (Disease Ontology)
- DOID:526
- Cross Reference ID (Disease Ontology)
- EFO:0000765
- Cross Reference ID (Disease Ontology)
- ICD10CM:B20
- Cross Reference ID (Disease Ontology)
- MESH:D000163
- Cross Reference ID (Disease Ontology)
- NCI:C2851
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:62479008
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0001175
- Exact Synonym (Disease Ontology)
- acquired Immune deficiency
- Exact Synonym (Disease Ontology)
- AIDS
- Disase Synonym (Disease Ontology)
- acquired immune deficiency syndrome
- MeSH unique ID (MeSH (Medical Subject Headings))
- D000163